136 related articles for article (PubMed ID: 2981718)
1. Vasoactive intestinal peptide receptor activity in human fetal enterocytes.
Gespach C; Chastre E; Emami S; Mulliez N
FEBS Lett; 1985 Jan; 180(2):196-202. PubMed ID: 2981718
[TBL] [Abstract][Full Text] [Related]
2. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
3. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology.
Gespach C; Bataille D; Vauclin N; Moroder L; Wünsch E; Rosselin G
Peptides; 1986; 7 Suppl 1():155-63. PubMed ID: 3018694
[TBL] [Abstract][Full Text] [Related]
4. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
Huang M; Rorstad OP
J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840
[TBL] [Abstract][Full Text] [Related]
5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
6. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
[TBL] [Abstract][Full Text] [Related]
7. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
[TBL] [Abstract][Full Text] [Related]
8. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.
Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G
Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308
[TBL] [Abstract][Full Text] [Related]
9. Functional receptors for VIP, GIP, glucagon-29 and -37 in the HGT-1 human gastric cancer cell line.
Emami S; Chastre E; Bodéré H; Gespach C; Bataille D; Rosselin G
Peptides; 1986; 7 Suppl 1():121-7. PubMed ID: 3018690
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
11. Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2.
Prost A; Emami S; Rosselin G; Gespach C
Biosci Rep; 1984 Dec; 4(12):1045-50. PubMed ID: 6085015
[TBL] [Abstract][Full Text] [Related]
12. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.
Laburthe M; Prieto JC; Amiranoff B; Dupont C; Hui Bon Hoa D; Rosselin G
Eur J Biochem; 1979 May; 96(2):239-48. PubMed ID: 88368
[TBL] [Abstract][Full Text] [Related]
13. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
14. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
15. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.
Binder HJ; Lemp GF; Gardner JD
Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
17. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.
Dharmsathaphorn K; Harms V; Yamashiro DJ; Hughes RJ; Binder HJ; Wright EM
J Clin Invest; 1983 Jan; 71(1):27-35. PubMed ID: 6294141
[TBL] [Abstract][Full Text] [Related]
18. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]